Plotti, F.; Terranova, C.; Guzzo, F.; De Cicco Nardone, C.; Luvero, D.; Bartolone, M.; Dionisi, C.; Benvenuto, D.; Fabris, S.; Ciccozzi, M.;
et al. Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study. Biomedicines 2021, 9, 55.
https://doi.org/10.3390/biomedicines9010055
AMA Style
Plotti F, Terranova C, Guzzo F, De Cicco Nardone C, Luvero D, Bartolone M, Dionisi C, Benvenuto D, Fabris S, Ciccozzi M,
et al. Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study. Biomedicines. 2021; 9(1):55.
https://doi.org/10.3390/biomedicines9010055
Chicago/Turabian Style
Plotti, Francesco, Corrado Terranova, Federica Guzzo, Carlo De Cicco Nardone, Daniela Luvero, Martina Bartolone, Camilla Dionisi, Domenico Benvenuto, Silvia Fabris, Massimo Ciccozzi,
and et al. 2021. "Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study" Biomedicines 9, no. 1: 55.
https://doi.org/10.3390/biomedicines9010055
APA Style
Plotti, F., Terranova, C., Guzzo, F., De Cicco Nardone, C., Luvero, D., Bartolone, M., Dionisi, C., Benvenuto, D., Fabris, S., Ciccozzi, M., Di Donato, V., Panici, P. B., & Angioli, R.
(2021). Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study. Biomedicines, 9(1), 55.
https://doi.org/10.3390/biomedicines9010055
